BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 14, 2004
View Archived Issues
New p38 kinase inhibitors in early development at BMS
Read More
Novel HCV NS5B inhibitors prepared and tested by GSK team
Read More
GSK claims 1,2-diazepane-based inhibitors of cathepsin K and other proteases
Read More
Chiron presents new melanocortin MC4 agonists for obesity and type 2 diabetes
Read More
New tachykinin antagonists for urinary disorders and other uses
Read More
Novel beta-secretase inhibitors for AD therapy covered by Merck patent
Read More
Milestone reached in Acadia-Allergan agreement
Read More
Access Pharmaceuticals signs licensing agreement with Wyeth for OraDisc
Read More
BioMimetic Pharmaceuticals and Luitpold Pharmaceuticals establish alliance
Read More
BioSante Pharmaceuticals announces DynPort subcontract to develop anthrax vaccines
Read More
FDA approves generic Ortho Tri-Cyclen
Read More
IND filed for phase I ThermoDox trial for liver cancer
Read More
Scripps Research Institute studies confirm utility of NeuGene drugs for SARS
Read More
Amylin files IND for PYY compound for obesity
Read More
Gilead submits IND for novel HIV protease inhibitor GS-9005
Read More
SBIR grant supports late-stage preclinical development of AV-101 for epilepsy
Read More
CYT-99-007 enters phase I
Read More
International pivotal Trabio study completes enrollment
Read More
Progress and plans for Sepracor pipeline
Read More
TKT drops plans to obtain U.S. approval for Replagal for Fabry's disease
Read More
Expert panel supports the benefits of inhaled corticosteroid use in asthma
Read More
Early marker for dementia studied in Down syndrome patients
Read More
Widespread use of alternative medicine in prostate cancer patients
Read More
Ro-04-6790 supports role of the 5-HT6 receptor in the regulation of cognitive function
Read More
Rosuvastatin more effective than atorvastatin in reducing LDL in genetic hypercholesterolemia
Read More
Identification of SARS coronavirus functional receptor
Read More
Xenical reported to induce weight loss and reduce the risk of type 2 diabetes in obese patients
Read More
An anti-IL-5 antibody found safe and effective in patients with HES
Read More
A new phase II clinical trial to evaluate Davanat with 5-FU in refractory colorectal cancer
Read More
Interferon gamma-1b in idiopathic pulmonary fibrosis
Read More